Importance of the pharmacological profile of thrombolytic agents in clinical practice
- 5 December 1991
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (16) , 3-7
- https://doi.org/10.1016/0002-9149(91)90298-y
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- An Interim Report of the Efficacy and Safety of Anisoylated Plasminogen Streptokinase Activator Complex (APSAC)1Drugs, 1987
- Evidence for the Progressive Uptake of Anisoylated Plasminogen Streptokinase Activator Complex by Clots in Human Plasma in VitroDrugs, 1987
- Preclinical Pharmacological Evaluation of Anisoylated Plasminogen Streptokinase Activator ComplexDrugs, 1987
- Coronary Thrombolysis for Evolving Myocardial InfarctionDrugs, 1984
- Intracoronary thrombolysis in patients with acute myocardial infarction: comparison of the efficacy of urokinase with streptokinase.Circulation, 1984
- Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.Circulation, 1981
- The Reduction of Infarct Size — An Idea Whose Time (For Testing) Has ComeCirculation, 1974